Brett Jackson is an associate in the firm’s Business Law Department and a member of its Technology group. Mr. Jackson represents startup and later-stage public and private companies in the software, technology and life sciences industries throughout their life cycle, with a particular focus on mergers, acquisitions, financings, secondary transactions, royalty transactions and other strategic transactions. He also represents venture capital and private equity funds focusing on technology and life sciences companies.
Among his financing matters, Mr. Jackson has represented EQRX in its equity financings, including a $500 million Series B financing, as well as Current, an online banking and payments company, as outside general counsel and in its equity financings, including its $131 million Series C financing with Tiger Global Management. Related to mergers and acquisitions, Mr. Jackson has represented Evariant in its sale to Healthgrades and Virtusa Corporation in its $2 billion sale to Baring Private Equity Asia.
Mr. Jackson earned his J.D. magna cum laude from Fordham University School of Law, and his M.A. and B.A. from Trinity College.
Technology, Technology M+A